Why Is Armata Pharma Stock Gaining Monday? - Armata Pharmaceuticals (AMEX:ARMP)

ARMP stock jumps 10% as Armata Pharmaceuticals prepares its AP-SA02 multi-phage candidate for a pivotal Phase 3 trial in late 2026.

Raccontata dabenzinga.com